Goodwill Pharma Plc Logo

Goodwill Pharma Plc

Develops, manufactures, and distributes medicines, supplements, and medical devices.

GWPH | BUD

Overview

Corporate Details

ISIN(s):
HU0000199575
LEI:
Country:
Hungary
Address:
N/A

Description

Goodwill Pharma Plc is a fully integrated pharmaceutical service provider engaged in the development, manufacturing, and distribution of therapeutic products. Its portfolio comprises medicines, food supplements, and medical devices. The company operates as a Contract Development and Manufacturing Organization (CDMO), offering comprehensive solutions that span the entire pharmaceutical lifecycle, from research and development to large-scale commercial manufacturing. Core services include product development, regulatory affairs, pharmacovigilance, production, logistics, and marketing support. Goodwill Pharma collaborates with academic institutions on research projects to foster innovation. The company primarily serves markets in Central and Eastern Europe, with an expanding international presence through various partnerships.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-09 10:10
Osztalékfizetés
Hungarian 126.3 KB
2025-12-01 08:28
Tájékoztatás alaptőkéről és szavazati jogokról
Hungarian 142.7 KB
2025-11-10 17:43
Tájékoztatás osztalékfizetésről
Hungarian 136.6 KB
2025-10-31 10:39
Tájékoztatás alaptőkéről és szavazati jogokról
Hungarian 153.7 KB
2025-10-01 09:03
Tájékoztatás alaptőkéről és szavazati jogokról
Hungarian 153.8 KB
2025-09-30 09:12
2025 I. féléves konszolidált tőzsdei jelentés
Hungarian 937.0 KB
2025-09-01 10:57
Tájékoztatás alaptőkéről és szavazati jogokról
Hungarian 153.3 KB
2025-08-25 10:06
Osztalékfizetés
Hungarian 137.4 KB
2025-08-01 09:49
Tájékoztatás alaptőkéről és szavazati jogokról
Hungarian 153.4 KB
2025-07-21 13:20
Osztalékfizetés
Hungarian 136.6 KB

Automate Your Workflow. Get a real-time feed of all Goodwill Pharma Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Goodwill Pharma Plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Goodwill Pharma Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.